Merck & Co (MRK:NYSE) Annual Reports & Investor Relations Material

Overview

Merck & Co., Inc., a global healthcare company, has been operating through two major segments, Pharmaceutical and Animal Health. The Pharmaceutical segment provides a wide range of human health pharmaceutical products such as oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. Additionally, it offers vaccine products for preventive pediatric, adolescent, and adult vaccines. On the other hand, the Animal Health segment develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services. Apart from that, it also provides digitally connected identification, traceability, and monitoring products. Merck & Co., Inc. caters to various healthcare providers such as drug wholesalers and retailers, hospitals, government agencies, managed healthcare providers, and physicians. The company has established collaborations with AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics LP, and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Established in 1891, Merck & Co., Inc. is headquartered in Rahway, New Jersey.

Frequently Asked Questions

What is Merck & Co's ticker?

Merck & Co's ticker is MRK

What exchange is Merck & Co traded on?

The company's shares trade on the NYSE stock exchange

Where are Merck & Co's headquarters?

They are based in Kenilworth, New Jersey

How many employees does Merck & Co have?

There are 10,000+ employees working at Merck & Co

What is Merck & Co's website?

It is merck.com

What type of sector is Merck & Co?

Merck & Co is in the Healthcare sector

What type of industry is Merck & Co?

Merck & Co is in the Drug Manufacturers - Major industry

Who are Merck & Co's peers and competitors?

The following five companies are Merck & Co's industry peers:

- Tricida

- Eli Lilly and Company

- Hikma Pharmaceuticals

- Amgen

- Astellas Pharma, Inc.